LON:POLX Polarean Imaging (POLX) Share Forecast, Price & News GBX 10.10 +0.70 (+7.45%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range 9.40▼ 10.3950-Day Range 9.38▼ 22.5052-Week Range 9▼ 84.20Volume1.77 million shsAverage Volume723,296 shsMarket Capitalization£21.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsHeadlinesProfileChartCompetitorsHeadlines About Polarean Imaging (LON:POLX) StockPolarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, Germany, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company is also involved in the development and manufacture of MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.Read More POLX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart POLX Stock News HeadlinesSeptember 27, 2023 | proactiveinvestors.comPolarean Imaging appoints new non-executive directorAugust 29, 2023 | finance.yahoo.comCMS grants reimbursement code for the Polarean XENOVIEW™ MRI TechnologySeptember 29, 2023 | Behind the Markets (Ad)6.5 Million Americans Are DESPERATE for This New Drug from One Tiny CompanyDecades of pent-up demand for this "first-ever" treatment could give you WINDFALL PROFITS... Click here to learn more >>>July 10, 2023 | finance.yahoo.comWe're Keeping An Eye On Polarean Imaging's (LON:POLX) Cash Burn RateJune 22, 2023 | bizjournals.comDurham medtech names new CEO to steer commercial launchJune 21, 2023 | finanznachrichten.dePolarean Imaging plc: Appointment of Dr. Christopher von Jako as new CEOMay 29, 2023 | finance.yahoo.comRecent 10% pullback isn't enough to hurt long-term Polarean Imaging (LON:POLX) shareholders, they're still up 59% over 5 yearsMay 26, 2023 | proactiveinvestors.comPolarean Imaging focused on gaining commercial traction for XENOVIEWSeptember 29, 2023 | Altimetry (Ad)WARNING: Seven millionaires to trigger sudden market panic?The next major selloff could be just days away…And seven powerful (yet completely unknown) insiders will be behind it all – and help corporate executives make a killing as it plays out. Here’s the full story.May 19, 2023 | msn.comThis penny stock has halved in 2023 to 28p! Should I buy?May 12, 2023 | marketwatch.comFirst clinical scan using XENOVIEW conducted at Cincinnati Children's Hospital Medical CenterMay 11, 2023 | finance.yahoo.comFirst clinical scan using XENOVIEW conducted at Cincinnati Children’s Hospital Medical CenterApril 17, 2023 | proactiveinvestors.comPolarean Imaging hires consultant to support commercial planningMarch 14, 2023 | proactiveinvestors.comPolarean Imaging gains access to funds after new bridge bank is formed; share suspension liftedMarch 13, 2023 | finance.yahoo.comU.K. tech, life sciences firms outline exposure to failed SVBFebruary 13, 2023 | proactiveinvestors.comPolarean Imaging looking to gain commercial traction for its XENOVIEWDecember 28, 2022 | proactiveinvestors.comPolarean Imaging PLC surges as XENOVIEW gets FDA green lightDecember 28, 2022 | proactiveinvestors.comPolarean Imaging surges as XENOVIEW gets FDA green lightNovember 29, 2022 | finance.yahoo.comPolarean Imaging plc (LON:POLX) has caught the attention of institutional investors who hold a sizeable 44% stakeOctober 27, 2022 | finance.yahoo.comPolarean Imaging's (LON:POLX) investors will be pleased with their notable 96% return over the last three yearsSeptember 22, 2022 | proactiveinvestors.comPolarean Imaging says US FDA requests additional information from manufacturing partner of its xenon-129 gas blend drugSeptember 6, 2022 | finance.yahoo.comPolarean Imaging plc (POLX.L)August 31, 2022 | marketwatch.comPolarean Imaging 1H Pretax Loss Widened on Greater Expenses, FX LossesJuly 24, 2022 | finance.yahoo.comHere's Why We're Not Too Worried About Polarean Imaging's (LON:POLX) Cash Burn SituationJune 19, 2022 | finance.yahoo.comWhat Is The Ownership Structure Like For Polarean Imaging plc (LON:POLX)?April 20, 2022 | proactiveinvestors.comPolarean Imaging says US regulator accepts updated submissionApril 14, 2022 | proactiveinvestors.comPolarean Imaging appoints former GE Healthcare exec as an independent directorSee More Headlines Receive POLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Polarean Imaging and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolLON:POLX CUSIPN/A CIKN/A Webwww.polarean.com Phone919 206 7900FaxN/AEmployees28Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-14,340,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-75.33% Return on Assets-40.85% Debt Debt-to-Equity Ratio2.30 Current Ratio5.50 Quick Ratio9.80 Sales & Book Value Annual Sales£1.03 million Price / Sales21.43 Cash FlowGBX 2.08 per share Price / Cash Flow4.93 Book ValueGBX 6 per share Price / Book1.70Miscellaneous Outstanding Shares215,850,000Free FloatN/AMarket Cap£22.07 million OptionableNot Optionable Beta0.76 The Best High-Yield Dividend Stocks for 2023Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Kenneth Paul West (Age 66)Chairman Comp: $38.25kDr. Bastiaan Driehuys Ph.D. (Age 54)Founder, CTO & Director Comp: $43.25kMr. Charles Fremont Osborne Jr. (Age 57)CFO & Director Comp: $315.42kMr. Clairis Richard Hullihen (Age 70)Exec. Officer Comp: $348.52kDr. Christopher Richard Von Jako Ph.D. (Age 53)CEO & Director Mr. Neil Wadehra (Age 43)VP of Operations Mr. Alex Dusek (Age 56)Chief Commercial Officer Mr. Stephen AustinCompany Sec.More ExecutivesKey CompetitorsInspiration Healthcare GroupLON:IHCSurgical Innovations GroupLON:SUNAdvanced OncotherapyLON:AVOMyHealthCheckedLON:MHCIntelligent Ultrasound GroupLON:IUGView All Competitors POLX Stock - Frequently Asked Questions How have POLX shares performed in 2023? Polarean Imaging's stock was trading at GBX 56 at the beginning of 2023. Since then, POLX stock has decreased by 81.7% and is now trading at GBX 10.23. View the best growth stocks for 2023 here. What other stocks do shareholders of Polarean Imaging own? Based on aggregate information from My MarketBeat watchlists, some companies that other Polarean Imaging investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP). What is Polarean Imaging's stock symbol? Polarean Imaging trades on the London Stock Exchange (LON) under the ticker symbol "POLX." How do I buy shares of Polarean Imaging? Shares of POLX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Polarean Imaging's stock price today? One share of POLX stock can currently be purchased for approximately GBX 10.23. How much money does Polarean Imaging make? Polarean Imaging (LON:POLX) has a market capitalization of £22.07 million and generates £1.03 million in revenue each year. The company earns £-14,340,000.00 in net income (profit) each year or GBX (0.05) on an earnings per share basis. How can I contact Polarean Imaging? Polarean Imaging's mailing address is 2500 Meridian Parkway, Suite 175, Durham, NC 27713, United States. The official website for the company is www.polarean.com. The company can be reached via phone at 919 206 7900. This page (LON:POLX) was last updated on 9/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polarean Imaging plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.